Clipperdist.info

MATERIAL SAFETY DATA SHEET
SECTION 1 - IDENTIFICATION OF PRODUCT AND COMPANY
Pfizer Inc
Emergency telephone
Pfizer Animal Health
Hours of operation
235 East 42nd Street
Telephone
New York, NY 10017
Trade names
Temaril-P® Tablets
Product name
Temaril-P® Tablets
Therapeutic use
Antitussive, Antipruritic, Antitussive, Anti-inflammatory Description
SECTION 2 - COMPOSITION
Ingredient(s) indicated as hazardous have been assessed under standardsfor workplace safety.
SECTION 3 - HAZARDS IDENTIFICATION
Signal word
CAUTION!
Statements of hazard
MAY CAUSE NERVOUS SYSTEM EFFECTS.
Eye effects
None known; however, direct contact with any foreign material may causeeye irritation.
Skin effects
Inhalation effects
Ingestion effects
See 'Other potential health effects', below.
Other potential health
This tablet contains material that can alter behavior, produce drowsiness, muscle tremors or rigidity, stupor, or other nervous system effects.
SECTION 3 - HAZARDS IDENTIFICATION . continued
This document has been prepared in accordance with standards forworkplace safety, which require the inclusion of all known hazards of theproduct or its ingredients regardless of the potential risk. Theprecautionary statements and warnings included may not apply in allcases. Your needs may vary depending upon the potential for exposure inyour workplace.
SECTION 4 - FIRST AID MEASURES
Wash hands and arms thoroughly after handling this material. Obtainmedical assistance if skin effects occur. Immediately flush eyes with water for at least 15 minutes. If irritationoccurs or persists, get medical attention. Inhalation
Remove to fresh air. If not breathing, give artificial respiration.
Ingestion
In the event of swallowing this material, seek immediate medical attention.
Note to physician
Medical treatment in cases of overexposure should be treated as anoverdosage of phenothiazine. Refer to current prescribing information orto local poison control information centers.
SECTION 5 - FIRE FIGHTING MEASURES
General hazard
This mixture is expected to support combustion, based on componentspresent.Toxic or corrosive vapours are expected if this material is heated.
Fire fighting instructions
Wear approved positive pressure, self-contained breathing apparatus andfull protective turn out gear. Move containers from fire area if possiblewithout increased personal risk. Dike area if possible to contain water forlater disposal. Extinguishing media
Water, dry powder or foam extinguishers are recommended. Carbondioxide extinguishers may be ineffective. Flash point
Hazardous combustion
Toxic or corrosive gases are expected in fires involving this mixture.
products
SECTION 6 - ACCIDENTAL RELEASE MEASURES
Review Sections 3, 8 and 12 before proceeding with clean up.
Small spill
Sweep spilled material into an approved container for disposal. Clean spillarea thoroughly. Prevent discharge to drains. SECTION 6 - ACCIDENTAL RELEASE MEASURES . continued
Large spill
Contain the source of the spill or leak if it is safe to do so. Scoop or shovelspilled material into a labeled container for disposal. Clean spill areathoroughly. Prevent discharge to drains. SECTION 7 - HANDLING AND STORAGE
General handling
IF TABLETS OR CAPSULES ARE CRUSHED AND/OR BROKEN,AVOID BREATHING DUST AND AVOID CONTACT WITH EYES,SKIN AND CLOTHING.
Storage conditions
Avoid prolonged storage at elevated temperatures (greater than roomtemperature, approximately 20 degrees C). Keep in tightly closedcontainers or packages away from moisture.
SECTION 8 - EXPOSURE CONTROLS/PERSONAL PROTECTION
Ventilation
Good general ventilation should be sufficient to control airborne levels.
Respiratory protection
Respirators are not required for normal use of this material.
Eye protection
Not required under normal conditions of use.
Skin protection
None required for the normal use of this material. Wash hands and armsthoroughly after handling this material. Clean up spills immediately.
Hand protection
Not required for the normal use of this material.
SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES
Physical form
Molecular weight
Molecular formula
Boiling point
Melting point
Vapor pressure
Water solubility
Solvent solubility
SECTION 10 - STABILITY AND REACTIVITY
Reactivity
Conditions to avoid
Direct sunlight, conditions that might generate heat and dispersion as adust cloud Incompatibilities
Hazardous
decomposition
products

Hazardous
polymerization
Explosive properties
Not identified. As with many organic dusts, explosions might result whenexcessive dust concentrations are present. SECTION 11 - TOXICOLOGY INFORMATION
Acute toxicity
Inhalation
Not applicable for solid, finished formulations. Ingestion
The calculated LD50 is less than 2000 mg/kg, based on effects ofindividual components and concentrations present.
Mutagenicity
Subchronic effects
Chronic effects/
carcinogenicity
Carcinogen status
None of the components of this formulation is listed as a carcinogen byIARC, NTP or OSHA. Reproductive effects
Teratogenicity
At increased risk from
Depressant effects of some medications or alcohol. exposure
Additional information
This material contains a phenothiazine tranquiliser. SECTION 12 - ECOLOGICAL INFORMATION
Environmental overview
The environmental characteristics of this mixture have not been fullyevaluated. Releases to the environment should be avoided.
SECTION 13 - DISPOSAL INFORMATION
Disposal procedure
Collect for recycling or recovery, if possible. Dispose of material on sitein a licensed chemical incinerator, if allowed by the incinerator license orpermit. If no on-site incinerator is available, dispose of material in alicensed commercial chemical incinerator. SECTION 14 - TRANSPORTATION INFORMATION
General shipping
Not regulated for transport under USDOT, EUADR, IATA, or IMDG instructions
SECTION 15 - REGULATORY INFORMATION
EU Classification
EU Labelling
EU Label Pictogram(s)
Safety phrases
Canadian WHMIS
This product has been classified in accordance with the hazard criteria ofthe CPR and the MSDS contains all of the information required by theCPR.
SECTION 16 - OTHER
Disclaimer
Pfizer Inc believes that the information contained in this Material
Safety Data Sheet is accurate, and while it is provided in good faith, it
is without a warranty of any kind, expressed or implied.

Source: http://clipperdist.info/sites/default/files/Temaril-P%20MSDS.pdf

slv.no

1. LEGEMIDLETS NAVN 2. KVALITATIV OG KVANTITATIV SAMMENSETNING 1 tablett inneholder:Haloperidol 1 mg. Haloperidol 4 mg. For fullstendig liste over hjelpestoffer se pkt. 6.1. 3. LEGEMIDDELFORM Tabletter. 1 mg tabletter: Hvite, runde, bikonvekse med delekors preget med ”JANSSEN” på den ene siden. 4 mg tabletter: Hvite, runde, bikonvekse med delekors preget med ”JANSSEN” på de

Microsoft word - tradravelli3.ruolo nel tx . doc.doc

US sonography in renal transplant: what role? Our experience in recent years, together with the literature of the same period, allows us to state that, from the early seventies (1), when our radiology colleagues were the first to undertake the US study of renal transplant, to these days, the technology has undergone fascinating developments and US has, at the same time, experienced a sort of “

Copyright © 2013-2018 Pharmacy Abstracts